UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Metabolic Syndrome and Prediction of Fatal and Non-Fatal Cardiovascular Events in a Newfoundland Population: Preliminary Findings From the Nfld Metsyn Follow-Up Study

Canadian journal of cardiology, 2013-10, Vol.29 (10), p.S326-S326

2013

Volltextzugriff (PDF)

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

The New England journal of medicine, 2019-10, Vol.381 (17), p.1609-1620

2019

Volltextzugriff (PDF)

Haemophilia and ageing

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (s3), p.8-12

2006

Volltextzugriff (PDF)

313 Does increased resting heart rate among individuals with metabolic syndrome enhance the prediction of CVD risk? An analysis of a Newfoundland population cohort

Canadian journal of cardiology, 2011-09, Vol.27 (5), p.S177-S178

2011

Volltextzugriff (PDF)

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction : the protective effects of captopril

Circulation (New York, N.Y.), 1994, Vol.89 (1), p.68-75

1994

Volltextzugriff (PDF)

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

European heart journal, 2014-12, Vol.35 (46), p.3277-3286

2014

Volltextzugriff (PDF)

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

European heart journal, 2014-09, Vol.35 (34), p.2295-2302

2014

Volltextzugriff (PDF)

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

The Lancet (British edition), 2008-09, Vol.372 (9644), p.1174-1183

2008

Volltextzugriff (PDF)

Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease

The New England journal of medicine, 2007-07, Vol.357 (3), p.217-227

2007

Volltextzugriff (PDF)

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina

Journal of the American College of Cardiology, 2001-02, Vol.37 (2), p.475-484

The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators

2001

Volltextzugriff (PDF)

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial

Circulation (New York, N.Y.), 2009-06, Vol.119 (22), p.2877-2885

2009

Volltextzugriff (PDF)

N-terminal proatrial natriuretic factor : an independent predictor of long-term prognosis after myocardial infarction

Circulation (New York, N.Y.), 1994-05, Vol.89 (5), p.1934-1942

1994

Volltextzugriff (PDF)

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

Circulation (New York, N.Y.), 2001-10, Vol.104 (14), p.1615-1621

2001

Volltextzugriff (PDF)

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

JACC. Heart failure, 2017-05, Vol.5 (5), p.317-326

2017

Volltextzugriff (PDF)

Influence of baseline lipids on effectiveness of pravastatin in the CARE trial

Journal of the American College of Cardiology, 1999-01, Vol.33 (1), p.125-130

1999

Volltextzugriff (PDF)

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.1886-1892

2000

Volltextzugriff (PDF)

Thermochemical Data of Organic Compounds

Second Edition., 1986

Volltextzugriff (PDF)

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial

European heart journal, 2000-09, Vol.21 (17), p.1473-1481

2000

Volltextzugriff (PDF)

Cardiovascular death and left ventricular remodeling two years after myocardial infarction : Baseline predictors and impact of long-term use of captopril : Information from the Survival and Ventricular Enlargement (SAVE) trial

Circulation (New York, N.Y.), 1997-11, Vol.96 (10), p.3294-3299

1997

Volltextzugriff (PDF)

The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment

Clinical pharmacology and therapeutics, 1994-08, Vol.56 (2), p.229-234

1994

Volltextzugriff (PDF)

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

Journal of the American College of Cardiology, 1996-04, Vol.27 (5), p.1119-1127

1996

Volltextzugriff (PDF)

Quality of Life among Patients Post-Myocardial Infarction at Baseline in the Survival and Ventricular Enlargement (SAVE) Trial

Quality of life research, 1994-04, Vol.3 (2), p.111-119

1994

Volltextzugriff (PDF)

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

JACC. Heart failure, 2017-05, Vol.5 (5), p.317-326

2017

Volltextzugriff (PDF)

CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus

Canadian journal of cardiology, 2010-08, Vol.26 (7), p.353-358

2010

Volltextzugriff (PDF)

Influence of Proteinuria on Cardiovascular Risk and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction

Journal of the American College of Cardiology, 2006-04, Vol.47 (8), p.1725-1727

2006

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(124)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(60)
Humans
(41)
Biological And Medical Sciences
(39)
Male
(30)
Physics
(29)
Cardiovascular System & Cardiology
(28)
Female
(28)
Physical Sciences
(28)
Cardiac & Cardiovascular Systems
(27)
Middle Aged
(26)
Medical Sciences
(23)
Aged
(21)
Fundamental And Applied Biological Sciences. Psychology
(16)
Cardiology. Vascular System
(14)
Heart
(13)
Coronary Heart Disease
(12)
Myocardial Infarction - Drug Therapy
(12)
Plant Sciences
(11)
Dna
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metabolic Syndrome and Prediction of Fatal and Non-Fatal Cardiovascular Events in a Newfoundland Population: Preliminary Findings From the Nfld Metsyn Follow-Up Study

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Haemophilia and ageing

313 Does increased resting heart rate among individuals with metabolic syndrome enhance the prediction of CVD risk? An analysis of a Newfoundland population cohort

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction : the protective effects of captopril

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial

N-terminal proatrial natriuretic factor : an independent predictor of long-term prognosis after myocardial infarction

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

Influence of baseline lipids on effectiveness of pravastatin in the CARE trial

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial

Thermochemical Data of Organic Compounds

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial

Cardiovascular death and left ventricular remodeling two years after myocardial infarction : Baseline predictors and impact of long-term use of captopril : Information from the Survival and Ventricular Enlargement (SAVE) trial

The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

Quality of Life among Patients Post-Myocardial Infarction at Baseline in the Survival and Ventricular Enlargement (SAVE) Trial

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus

Influence of Proteinuria on Cardiovascular Risk and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction

Suchergebnisse filtern